Incannex receives positive feedback from FDA for its brain injury treatment drug

Mugglehead
By Rowan DunneOct 11, 2022, 6:19 pm208 pts
Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL) has made additional progress with the development of its proprietary inhalable drug designed to treat brain injuries. On Tuesday, the Australian pharmaceutical company announced that it had completed a productive pre-Investigational New Drug Application…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Why Is Texas Supporting Psychedelics Research While Criminalizing Cannabis? (Op-Ed) 59

Blow Smoke, Not Your Cover with New Smokebuddy Bundles 34

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.